PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS

被引:403
作者
CHRISTENSEN, AV
ARNT, J
HYTTEL, J
LARSEN, JJ
SVENDSEN, O
机构
关键词
D O I
10.1016/0024-3205(84)90607-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
引用
收藏
页码:1529 / 1540
页数:12
相关论文
共 45 条
[1]
ARNT J, 1982, ACTA PHARMACOL TOX, V51, P321
[2]
ARNT J, 1981, NEUROPHARMACOLOGY, V20, P1331
[3]
DIFFERENTIAL REVERSAL BY SCOPOLAMINE AND THIP OF THE ANTISTEREOTYPIC AND CATALEPTIC EFFECTS OF NEUROLEPTICS [J].
ARNT, J ;
CHRISTENSEN, AV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 69 (01) :107-111
[5]
ARNT J, 1982, British Journal of Pharmacology, V77, p308P
[6]
CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140
[7]
CARLSSON A, 1966, PHARMACOL REV, V18, P541
[8]
GABA-DOPAMINE-NEUROLEPTIC INTERACTION AFTER SYSTEMIC ADMINISTRATION [J].
CHRISTENSEN, AV ;
ARNT, J ;
SCHEELKRUGER, J .
BRAIN RESEARCH BULLETIN, 1980, 5 :885-890
[9]
DECREASED ANTI-STEREOTYPIC EFFECT OF NEUROLEPTICS AFTER ADDITIONAL TREATMENT WITH A BENZODIAZEPINE, A GABA AGONIST OR AN ANTICHOLINERGIC COMPOUND [J].
CHRISTENSEN, AV ;
ARNT, J ;
SCHEELKRUGER, J .
LIFE SCIENCES, 1979, 24 (15) :1395-1402
[10]
CHRISTENSEN AV, 1982, PHARM INT, V3, P329